Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 10/20 | 0.48 |
| ▸ | HTR2C | P28335 | 8/20 | 0.48 |
| ▸ | MAOA | P21397 | 7/20 | 0.48 |
| ▸ | KDM1A | O60341 | 5/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3189760 | 1.00 | MAOB (0.48) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL9461901 | 0.88 | MAOB (0.42) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL6582328 | 0.83 | MAOB (0.45) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL1697579 | 0.80 | MAOB (0.41) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL2827113 | 0.78 | KDM1A (0.52) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL4890488 | 0.78 | KDM1A (0.52) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL5139636 | 0.78 | KDM1A (0.52) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL15466643 | 0.78 | MAOB (0.41) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL446481 | 0.77 | MAOB (0.48) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL12728259 | 0.77 | MAOB (0.48) | MAOBHTR2CMAOAKDM1ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4582500-A1 | PHOTOCURABLE INK-JET INK COMPOSITION | Sakata INX Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-119836455-A | Ink composition for ultraviolet light shielding and method for producing substrate having embossed surface using the same | 阪田油墨股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-119585374-A | Photo-curable ink composition for inkjet | 科巨希化学股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| WO-2024203485-A1 | RESIN COMPOSITION FOR OPTICAL IMPRINT MOLDS, AND OPTICAL IMPRINT MOLD | 日本ゼオン株式会社 | 2024-10-03 | — | — | WO | disclosed |
| EP-4400223-A1 | DIGITAL EMBOSSING CREATION METHOD | Sakata INX Corporation (JP) | 2024-07-17 | — | — | EP | disclosed |
| EP-4397726-A1 | PHOTOCURABLE INK COMPOSITION FOR INKJET PRINTING | Sakata INX Corporation (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-20240218195-A1 | ELECTRON BEAM-CURABLE PRINTING INK COMPOSITION AND PRINTED MATTER OBTAINED BY PRINTING WITH ELECTRON BEAM-CURABLE PRINTING INK COMPOSITION | SAKATA INX CORPORATION (JP) | 2024-07-04 | — | — | US | disclosed |
| WO-2024095560-A1 | INK COMPOSITION FOR BLOCKING UV RAYS, AND METHOD FOR PRODUCING SUBSTRATE HAVING EMBOSSED SURFACE USING SAME | サカタインクス株式会社 | 2024-05-10 | — | — | WO | disclosed |
| EP-4365250-A1 | MIGRATION-PREVENTING COATING AGENT | Sakata INX Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| WO-2024089979-A1 | POWDER DEPOSITION PRINTING METHOD | サカタインクス株式会社 | 2024-05-02 | — | — | WO | disclosed |
| US-7662969-B2 | Efficient aziridination of olefins catalyzed by dirhodium catalysts | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2010-02-16 | — | — | US | disclosed |
| US-20090057960-A1 | RESIN MOLD AND PROCESS FOR PRODUCING A MOLDED ARTICLE USING THE MOLD | ZEON CORPORATION (JP) | 2009-03-05 | — | — | US | disclosed |
| CN-101151132-A | Resin mold and method for producing molded article using the same | ZEON CORP (JP) | 2008-03-26 | — | — | CN | disclosed |
| US-20060211870-A1 | Efficient aziridination of olefins catalyzed by dirhodium catalysts | THE UNIVERSITY OF MARYLAND COLLEGE PARK (US) | 2006-09-21 | — | — | US | disclosed |
| CN-1241950-C | Polymerizable composition | TOYO INK MFG CO (JP) | 2006-02-15 | — | — | CN | disclosed |
| US-6900250-B2 | Polymerizable composition | TOYO INK MFG. CO., LTD. (JP) | 2005-05-31 | — | — | US | disclosed |
| CN-1458938-A | Polymerizable composition | TOYO INK MFG CO (JP) | 2003-11-26 | — | — | CN | disclosed |
| US-20030212162-A1 | Photopolymerization using photoinitiators | TOYO INK MFG. CO., LTD. (JP) | 2003-11-13 | — | — | US | disclosed |
| EP-0018894-B1 | ESTERS OF ALLETHROLONE DERIVATIVES AND CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM | ROUSSEL-UCLAF (FR) | 1982-02-17 | — | — | EP | disclosed |
| EP-0018894-A1 | Esters of allethrolone derivatives and carboxylic acids, process for their preparation and the compositions containing them | ROUSSEL-UCLAF (FR) | 1980-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211870-A1 | Efficient aziridination of olefins catalyzed by dirhodium catalysts | RPL24, RPL26, ZDHHC20 | MAOB 2382/4885HTR2C 3127/4885MAOA 2210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.